| BEXUX | FWWNX | BEXUX / FWWNX | |
| Total Expense Ratio | 1.12 | 0.62 | 181% |
| Annual Report Gross Expense Ratio | 1.12 | 0.62 | 181% |
| Fund Existence | 11 years | 6 years | - |
| Gain YTD | 16.771 | 16.494 | 102% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.84B | 90B | 4% |
| Annual Yield % from dividends | 1.76 | 1.21 | 145% |
| Returns for 1 year | 19.36 | 17.30 | 112% |
| Returns for 3 years | 70.16 | 54.17 | 130% |
| Returns for 5 years | 22.20 | 19.50 | 114% |
| Returns for 10 years | 106.30 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTEX | 20.74 | 0.56 | +2.78% |
| ICON Health and Information Tech Instl | |||
| MGIBX | 45.07 | N/A | N/A |
| MFS International Intrinsic Equity B | |||
| FACTX | 56.71 | N/A | N/A |
| Fidelity Advisor Health Care M | |||
| GCMTX | 37.39 | N/A | N/A |
| Goldman Sachs Mid Cap Value Inv | |||
| MNHRX | 26.69 | N/A | N/A |
| Manning & Napier Pro-Blend Max Term R | |||